Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

Hospitalized COVID-19 sufferers usually current with a big spectrum of scientific signs. There’s a vital want to raised perceive the immune responses to SARS-CoV-2 that result in both decision or exacerbation of the scientific illness. Right here, we study longitudinal plasma samples from hospitalized COVID-19 sufferers with differential scientific consequence. We carry out immune-repertoire evaluation together with cytokine, hACE2-receptor inhibition, neutralization titers, antibody epitope repertoire, antibody kinetics, antibody isotype and antibody affinity maturation towards the SARS-CoV-2 prefusion spike protein.

Deadly circumstances reveal excessive plasma ranges of IL-6, IL-8, TNFα, and MCP-1, and sustained excessive share of IgA-binding antibodies to prefusion spike in contrast with non-ICU survivors. Illness decision in non-ICU and ICU sufferers associates with antibody binding to the receptor binding motif and fusion peptide, and antibody affinity maturation to SARS-CoV-2 prefusion spike protein. Right here, we offer perception into the immune parameters related to scientific illness severity and disease-resolution consequence in hospitalized sufferers that would inform improvement of vaccine/therapeutics towards COVID-19.

Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based evaluation

Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic necrotizing vasculitides related to important morbidity and mortality. Given the immunosuppression used to handle these situations, it will be important for clinicians to acknowledge issues, particularly infectious ones, which can come up throughout therapy. Kaposi sarcoma (KS) is a lymphoangioproliferative neoplasm attributable to human herpes virus 8 (HHV-8). Its cutaneous manifestations can mimic vasculitis.

We describe a 77-year-old man with microscopic polyangiitis with pulmonary-renal syndrome handled with prednisone and intravenous cyclophosphamide who developed KS (HHV-Eight constructive) after 2 months of therapy. Cyclophosphamide was discontinued and prednisone step by step lowered with enchancment and scientific stabilization of KS lesions.

This complete evaluation contains all revealed circumstances of KS in sufferers with AAV, with a aim to summarize potential danger components together with the scientific traits of vasculitis, therapy and outcomes of sufferers with this uncommon complication of immunosuppressive remedy. We additionally expanded our literature evaluation to KS in different types of systemic vasculitis. Our case-based evaluation emphasizes the significance of contemplating infectious issues of immunosuppressive remedy, particularly glucocorticoids, and highlights the uncommon affiliation of KS in systemic vasculitis.

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

Aggressive Immunoassay of SARS-CoV-2 Utilizing Pig Sera-Derived Anti-SARS-CoV-2 Antibodies

Anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) nucleoprotein (NP) antibodies have been remoted from pig sera utilizing human SARS-CoV-2 NP-immobilized magnetic beads. The binding properties of the remoted antibodies towards SARS-CoV-2 NP have been examined by way of movement cytometry utilizing SARS-CoV-2 NP-immobilized magnetic beads. A aggressive immunoassay was developed for detecting SARS-CoV-2 NP in addition to SARS-CoV-2 within the tradition fluid utilizing magnetic beads with immobilized anti-SARS-CoV-2 NP antibodies. Selectivity assessments have been carried out throughout the aggressive immunoassay for SARS-CoV, MERS-CoV, and CoV pressure 229E within the tradition fluid.

Discount in Nesfatin-1 Ranges within the Cerebrospinal Fluid and Elevated Nigrostriatal Degeneration Following Ventricular Administration of Anti-nesfatin-1 Antibody in Mice

Nesfatin-1 is one among a number of brain-gut peptides which have a detailed relationship with the central dopaminergic system. Our earlier research have proven that nesfatin-1 is able to defending nigral dopaminergic neurons towards 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. A current research additionally revealed a diminished blood degree of nesfatin-1 in sufferers with Parkinson’s illness (PD). The present research was designed to analyze whether or not diminished nesfatin-1 in cerebrospinal fluid (CSF) induces nigrostriatal system degeneration.

An intra-cerebroventricular (ICV) injection approach was used to manage anti-nesfatin-1 antibody straight into the lateral ventricle of the mind. Enzyme-linked immunosorbent assay (ELISA) outcomes confirmed that ICV injection of anti-nesfatin-1 antibody into the lateral ventricle of the mind as soon as day by day for two weeks precipitated a major discount in nesfatin-1 ranges within the CSF (93.1%).

Remedy with anti-nesfatin-1 antibody resulted in a considerable loss (23%) of TH-positive (TH+) dopaminergic neurons within the substantia nigra pars compacta (SNpc), as proven by immunofluorescence staining, a depletion in dopamine and its metabolites within the striatum detected by high-performance liquid chromatography (HPLC), and apparent nuclear shrinkage and mitochondrial lesions in dopaminergic neurons within the SNpc detected by transmission electron microscopy (TEM).

Moreover, the outcomes from our Western blot and ELISA experiments demonstrated that anti-nesfatin-1 antibody injection induced an upregulation of caspase-Three activation, elevated the expression of p-ERK, and elevated brain-derived neurotrophic issue (BDNF) ranges within the SNpc. Taken collectively, these observations recommend that diminished nesfatin-1 within the mind could induce nigrostriatal dopaminergic system degeneration; this impact could also be mediated by way of mitochondrial dysfunction-related apoptosis. Our information help a task of nesfatin-1 in sustaining the conventional physiological perform of the nigrostriatal dopaminergic system.

Convergent antibody evolution and clonotype enlargement following influenza virus vaccination

Current advances in high-throughput single cell sequencing have opened up new avenues into the investigation of B cell receptor (BCR) repertoires. On this research, PBMCs have been collected from 17 human contributors vaccinated with the split-inactivated influenza virus vaccine throughout the 2016-2017 influenza season. A mix of Immune Repertoire Seize (IRCTM) expertise and IgG sequencing was carried out on ~7,800 plasmablast (PB) cells and preferential IgG heavy-light chain pairings have been investigated. In some contributors, a single expanded clonotype accounted for ~22% of their PB BCR repertoire.

Roughly 60% (10/17) of contributors skilled convergent evolution, possessing public PBs that have been elicited independently in a number of contributors. Binding profiles of 1 non-public and three public PBs confirmed they have been all subtype-specific, cross-reactive hemagglutinin (HA) head-directed antibodies.

Anti-FGFR-5 antibody

STJ93067 200 µl
EUR 197
Description: Rabbit polyclonal to FGFR-5.

Anti-FGFR-4 antibody

STJ97668 200 µl
EUR 197
Description: Rabbit polyclonal to FGFR-4.

Anti-FGFR-4 antibody

STJ98068 100 µl
EUR 234
Description: Mouse monoclonal to FGFR-4.

Anti-FGFR-4 antibody

STJ98069 100 µl
EUR 234
Description: Mouse monoclonal to FGFR-4.

FGFR-3 Polyclonal Antibody

40925-100ul 100ul
EUR 252

FGFR-3 Polyclonal Antibody

40925-50ul 50ul
EUR 187

FGFR-3 Polyclonal Antibody

ABP54250-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-3 at AA rangle: 100-180
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-3 from Human, Mouse, Rat. This FGFR-3 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-3 at AA rangle: 100-180

FGFR-3 Polyclonal Antibody

ABP54250-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-3 at AA rangle: 100-180
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-3 from Human, Mouse, Rat. This FGFR-3 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-3 at AA rangle: 100-180

FGFR-3 Polyclonal Antibody

ABP54250-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-3 at AA rangle: 100-180
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-3 from Human, Mouse, Rat. This FGFR-3 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-3 at AA rangle: 100-180

FGFR-3 Polyclonal Antibody

ES5249-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against FGFR-3 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

FGFR-3 Polyclonal Antibody

ES5249-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against FGFR-3 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 349

Anti-Phospho-FGFR-4 (Y642) antibody

STJ90669 200 µl
EUR 197
Description: Rabbit polyclonal to Phospho-FGFR-4 (Y642).

FGFR-5 antibody

22119-100ul 100ul
EUR 390

FGFR (pY766) Antibody

abx031862-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.

FGFR (pY766) Antibody

abx031862-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.

Rabbit anti-LukAB pAb (neutralizing)

0313-001 500ug
EUR 405
Description:
  • Related to: Staphylococcus
  • Applications: Neutralization

Interferon alpha Neutralizing Antibody

20-abx137013
  • EUR 356.00
  • EUR 523.00
  • 0.5 mg
  • 1 mg
  • Shipped within 5-10 working days.

FGFR (pY653 / 654) Antibody

abx031861-400ul 400 ul
EUR 551
  • Shipped within 5-10 working days.

FGFR (pY653 / 654) Antibody

abx031861-80l 80 µl
EUR 321
  • Shipped within 5-10 working days.

FGFR-4 Polyclonal Antibody

ABP57401-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-4
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-4 from Human. This FGFR-4 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-4

FGFR-4 Polyclonal Antibody

ABP57401-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-4
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-4 from Human. This FGFR-4 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-4

FGFR-4 Polyclonal Antibody

ABP57401-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-4
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-4 from Human. This FGFR-4 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-4

FGFR-5 Polyclonal Antibody

ABP55629-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-5 at AA range: 130-210
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-5 from Human, Mouse. This FGFR-5 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-5 at AA range: 130-210

FGFR-5 Polyclonal Antibody

ABP55629-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-5 at AA range: 130-210
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-5 from Human, Mouse. This FGFR-5 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-5 at AA range: 130-210

FGFR-5 Polyclonal Antibody

ABP55629-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from the Internal region of human FGFR-5 at AA range: 130-210
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-5 from Human, Mouse. This FGFR-5 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human FGFR-5 at AA range: 130-210

FGFR-4 Polyclonal Antibody

ES8394-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against FGFR-4 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

FGFR-4 Polyclonal Antibody

ES8394-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against FGFR-4 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

FGFR-5 Polyclonal Antibody

ES6628-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against FGFR-5 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

FGFR-5 Polyclonal Antibody

ES6628-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against FGFR-5 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody

abx411283-02mg 0.2 mg
EUR 565
  • Shipped within 1 week.

Anti-VEGF Receptor 3/FLT4 Antibody

A01276-3 100ug/vial
EUR 334

Anti-Human Ki67 Antibody

M00254-3 100ul
EUR 397
Description: Rabbit Polyclonal Human Ki67 Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat.

Anti-Human IBA1 Antibody

M01394-3 100ul
EUR 397
Description: Chicken Polyclonal Human IBA1 Antibody. Validated in IF, IHC, WB and tested in Human.

Anti-14-3-3 alpha + beta Rabbit Monoclonal Antibody

M02431-3 100ug/vial
EUR 397
Description: Rabbit Monoclonal 14-3-3 alpha + beta Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC, WB and tested in Human, Mouse, Rat.

Anti-active Caspase-3 Rabbit Monoclonal Antibody

M00334-3 100ug/vial
EUR 397
Description: Anti-active Caspase-3 Rabbit Monoclonal Antibody tested for IF, IHC, ICC, WB in Human

Anti-Galectin 3/LGALS3 Antibody (monoclonal, 12B12)

M00621-3 100ug/vial
EUR 334

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC)

abx411284-01mg 0.1 mg
EUR 509
  • Shipped within 1 week.

Polyclonal Phospho-FGFR(Y766) Antibody

APR05124G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Phospho-FGFR(Y766) . This antibody is tested and proven to work in the following applications:

Horse Anti-Rabies Virus IgG (Fab2), neutralizing

RBV16-Fab2 100 ul
EUR 445

Recombinant Human FGFR-2 Protein

RP00046 5 μg
EUR 136

Recombinant human FGFR-2 Protein

RP01213 10 μg
EUR 155

Anti-Glyceraldehyde 3-Phosphate Dehydrogenase [GAPDH] Monoclonal Antibody

M00227-3 100ul
EUR 397
Description: Mouse Monoclonal Glyceraldehyde 3-Phosphate Dehydrogenase [GAPDH] Antibody. Validated in IHC, WB and tested in Equine.

Monoclonal NGF/proNGF Neutralizing Antibody Antibody

AMM06679G 0.05mg
EUR 528
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E

Goat Anti-Human Respiratory Syncytial Virus (RSV) IgG, neutralizing

RSV12-S 100 ul
EUR 457

Anti-RAB3GAP2 Antibody

A07244-3 100ug/vial
EUR 334

Anti-FOXI1 Antibody

A07512-3 100ug/vial
EUR 334

Anti-IL17B Antibody

A10846-3 100ug/vial
EUR 294

Anti-RBMS3 Antibody

A12416-3 100ug/vial
EUR 334

Anti-SENP6 Antibody

A05088-3 100ug/vial
EUR 294

Anti-LBP Antibody

A00809-3 100ug/vial
EUR 294

Anti-IL22 Antibody

A00963-3 100ug/vial
EUR 294

Anti-MBL2 Antibody

A01000-3 100ug/vial
EUR 294

Anti-KCNH1 Antibody

A01036-3 100ug/vial
EUR 294

Anti-IL12B Antibody

A01152-3 100ug/vial
EUR 334

Anti-PRMT1 Antibody

A01417-3 100ug/vial
EUR 294

Anti-TFF3 Antibody

A01738-3 100ug/vial
EUR 334

Anti-IFNAR2 Antibody

A02056-3 100ug/vial
EUR 334

Anti-IL17F Antibody

A02062-3 100ug/vial
EUR 294

Anti-TREM1 Antibody

A02135-3 100ug/vial
EUR 294

Anti-SENP1 Antibody

A02156-3 100ug/vial
EUR 294

Anti-BTC Antibody

A02171-3 100ug/vial
EUR 334

Anti-EEA1 Antibody

A02296-3 100ug/vial
EUR 294

Anti-JAK3 Antibody

A02598-3 100ug/vial
EUR 294

Anti-APRT Antibody

A02721-3 100ug/vial
EUR 334

Anti-CUL2 Antibody

A02986-3 100ug/vial
EUR 334

Anti-EIF4A1 Antibody

A03922-3 100ug/vial
EUR 334

Anti-SLIT1 Antibody

A04113-3 100ug/vial
EUR 294

Anti-SORBS1 Antibody

A04426-3 100ug/vial
EUR 334

Anti-VEGFB Antibody

A04494-3 100ug/vial
EUR 294

Anti-Nanog Antibody

A00153-3 100ug/vial
EUR 294

Anti-IL17C Antibody

A00164-3 100ug/vial
EUR 294

Anti-AICDA Antibody

A00267-3 100ug/vial
EUR 294

Anti-ICOS Antibody

A00291-3 100ug/vial
EUR 334

Anti-TLR1 Antibody

A00429-3 100ug/vial
EUR 334

Anti-IGFBP3 Antibody

A00435-3 100ug/vial
EUR 294

Anti-TANK Antibody

A00445-3 100ug/vial
EUR 334

Anti-FGF23 Antibody

A00478-3 100ug/vial
EUR 294

Anti-Leptin Antibody

A00479-3 100ug/vial
EUR 294

Anti-CD5 Antibody

A00480-3 100ug/vial
EUR 334

Anti-SYK Antibody

A00490-3 100ug/vial
EUR 294

Anti-PON1 Antibody

A00516-3 100ug/vial
EUR 334

Anti-CSF1 Antibody

A00620-3 100ug/vial
EUR 294

Anti-PYROXD1 Antibody

A17214-3 100ug/vial
EUR 334

Anti-CNP Antibody

M01017-3 100ul
EUR 397
Description: Chicken Polyclonal CNP Antibody. Validated in IHC, WB and tested in Equine, Pig.

Anti-GAP43 Antibody

M01868-3 100ul
EUR 397
Description: Rabbit Polyclonal GAP43 Antibody. Validated in IF, IHC, WB and tested in Bovine, Chicken, Equine, Human, Mouse, Pig, Rat.

Anti-Calretinin Antibody

M04255-3 100ul
EUR 397
Description: Rabbit Polyclonal Calretinin Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat.

D/E NEUTRALIZING AGAR

D04-112-10kg 10 kg
EUR 1536

D/E NEUTRALIZING AGAR

D04-112-2Kg 2 Kg
EUR 373

D/E NEUTRALIZING AGAR

D04-112-500g 500 g
EUR 138

D/E NEUTRALIZING BROTH

D04-115-10kg 10 kg
EUR 1009

D/E NEUTRALIZING BROTH

D04-115-2kg 2kg
EUR 258

D/E NEUTRALIZING BROTH

D04-115-500g 500 g
EUR 107

Anti-MRP1 (human) Monoclonal Antibody (QCRL-1)

M00872-3 1ml
EUR 675
Description: Mouse Monoclonal MRP1 (human) Antibody (QCRL-1). Validated in IP, IF and tested in Human.

FGFR-4 (phospho Tyr642) Polyclonal Antibody

ABP54252-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from human FGFR-4 around the phosphorylation site of Y642
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-4 phospho Tyr642) from Human, Mouse, Rat. This FGFR-4 phospho Tyr642) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human FGFR-4 around the phosphorylation site of Y642

FGFR-4 (phospho Tyr642) Polyclonal Antibody

ABP54252-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from human FGFR-4 around the phosphorylation site of Y642
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-4 phospho Tyr642) from Human, Mouse, Rat. This FGFR-4 phospho Tyr642) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human FGFR-4 around the phosphorylation site of Y642

FGFR-4 (phospho Tyr642) Polyclonal Antibody

ABP54252-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from human FGFR-4 around the phosphorylation site of Y642
  • Applications tips:
Description: A polyclonal antibody for detection of FGFR-4 phospho Tyr642) from Human, Mouse, Rat. This FGFR-4 phospho Tyr642) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human FGFR-4 around the phosphorylation site of Y642

FGFR-4 (phospho Tyr642) Polyclonal Antibody

ES5251-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against FGFR-4 (phospho Tyr642) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

FGFR-4 (phospho Tyr642) Polyclonal Antibody

ES5251-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against FGFR-4 (phospho Tyr642) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Rabbit Anti-Poliomyelitis Virus 3 (Leon1,Ch,2ab strain) antiserum, neutralizing

POLV32-S 100 ul
EUR 457

G. Pig anti-Poliomyelitis Virus 3 (sabin strain, native) antiserum, neutralizing

POLV33-S 100 ul
EUR 457

Anti-Aldolase/ALDOA Antibody

A05022-3 100ug/vial
EUR 334

Anti-BCMA/Tnfrsf17 Antibody

A01014-3 100ug/vial
EUR 294

Anti-RANK/Tnfrsf11a Antibody

A01064-3 100ug/vial
EUR 294

Anti-CD40L/CD40LG Antibody

A01114-3 100ug/vial
EUR 294

Anti-PXR/NR1I2 Antibody

A01133-3 100ug/vial
EUR 334

Anti-TAPA1/Cd81 Antibody

A01281-3 100ug/vial
EUR 294

Anti-TrkB/NTRK2 Antibody

A01388-3 100ug/vial
EUR 294

Anti-CD31/Pecam1 Antibody

A01513-3 100ug/vial
EUR 334

Anti-FPRL1/FPR2 Antibody

A01980-3 100ug/vial
EUR 334

Anti-NRAMP1/SLC11A1 Antibody

A02547-3 100ug/vial
EUR 334

Anti-CD13/Anpep Antibody

A02591-3 100ug/vial
EUR 334

Anti-HE4/Wfdc2 Antibody

A02685-3 100ug/vial
EUR 334

Anti-B7H4/VTCN1 Antibody

A02821-3 100ug/vial
EUR 294

Anti-GITR/Tnfrsf18 Antibody

A03125-3 100ug/vial
EUR 294

Anti-Thrombopoietin/THPO Antibody

A03222-3 100ug/vial
EUR 294

Collectively, this high-resolution antibody repertoire evaluation demonstrated the influence evolution can have on BCRs in response to influenza virus vaccination, which may information future common influenza prophylactic approaches.

 

Leave a Reply

Your email address will not be published. Required fields are marked *